Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders

Movement Disorders

Volumn 30, Issue 9, 2015, Pages 1155-1170

  Tremblay, Léon ^a   Worbe, Yulia ^b   Thobois, Stéphane ^a,c   Sgambato Faure, Véronique ^a   Féger, Jean ^b  

^a UNIVERSITÉ LYON 1   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

Author keywords

basal ganglia; deep brain stimulation; dopamine; dopamine dysregulation syndrome; dyskinesia; fast spiking interneurons; GABA inhibition; impulse control disorders; MPTP; nonhuman primate; pallidum; Parkinson's disease; serotonin; striatum; Tourette's syndrome

Indexed keywords

ANIMAL; BASAL GANGLION; HUMAN; MENTAL DISEASE; MOTOR DYSFUNCTION; NERVE CELL NETWORK; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BASAL GANGLIA; HUMANS; MENTAL DISORDERS; MOVEMENT DISORDERS; NERVE NET;

EID: 85027956885     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26199     Document Type: Review

References (161)

1. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
2. Parent A. and Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995;20:91-127.
3. Haber SN. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003;26:317-330.
4. Selemon LD, Goldman-Rakic PS. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 1985;5:776-794.
5. Percheron G, Yelnik J, François C. A Golgi analysis of the primate globus pallidus. III. Spatial organization of the striato-pallidal complex. Comp Neurol 1984;227:214-227.
6. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000;42:183-200.
7. Middleton FA, Strick PL. Basal-ganglia ‘projections’ to the prefrontal cortex of the primate. Cereb Cortex 2002;12:926-935.
8. Middleton FA, Strick PL. New concepts about the organization of basal ganglia output. Adv Neurol 1997;74:57-68.
9. Saga Y, Hirata Y, Takahara D, et al. Origins of multisynaptic projections from the basal ganglia to rostrocaudally distinct sectors of the dorsal premotor area in macaques. Eur J Neurosci 2011;33:285-297.
10. Fuster JM. The prefrontal cortex an update: time is of the essence. Neuron 2001;30:319-333.
11. McFarland NR, Haber SN. Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J Neurosci 2002;22:8117-8132.
12. Tremblay L, Worbe Y, Hollerman R. The ventral striatum: a heterogeneous structure involved in reward processing, motivation and decision-making. In: Dr. Jean-Claude Dreher and Léon Tremblay, editors. Handbook of Reward and Decision Making. Oxford, UK: Academic Press; 2009:51-77.
13. Schultz W, Romo R. Role of primate basal ganglia and frontal cortex in the internal generation of movements. I. Preparatory activity in the anterior striatum. Exp Brain Res 1992;91:363-384.
14. Knutson B, Fong GW, Adams CM, Varner JL, Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 2001;12:3683-3687.
15. O'Doherty JP, Deichmann R, Critchley HD, Dolan RJ. Neural responses during anticipation of a primary taste reward. Neuron 2002;33:815-826.
16. Ernst M, Nelson EE, McClure EB, et al. Choice selection and reward anticipation: an fMRI study. Neuropsychologia 2004;42:1585-1597.
17. Hollerman JR, Tremblay L, Schultz W. Influence of reward expectation on behavior-related neuronal activity in primate striatum. J Neurophysiol 1998;80:947-963.
18. Lehéricy S, Bardinet E, Tremblay L, et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb Cortex 2006;16:149-161.
19. Alexander GE, Crutcher MD. Preparation for movement: neural representations of intended direction in three motor areas of the monkey. J Neurophysiol 1990;64:133-150.
20. Romo RE, Scarnati E, Schultz W. Role of primate basal ganglia and frontal cortex in the internal generation of movements. II. Movement-related activity in the anterior striatum. Exp Brain Res 1992;91:385-395.
21. Schultz W, Apicella P, Scarnati E, Ljungberg T. Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 1992;12:4595-4610.
22. Gerardin E, Pochon JB, Poline JB, et al. Distinct striatal regions support movement selection, preparation and execution. Neuroreport 2004;15:2327-2331.
23. Berridge KC, Kringelbach ML. Neuroscience of affect: brain mechanisms of pleasure and displeasure. Curr Opin Neurobiol 2013;23:294-303.
24. Berridge KC. ‘Liking’ and ‘wanting’ food rewards: brain substrates and roles in eating disorders. Physiol Behav 2009;97:537-550.
25. Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 2010;65:585-596.
26. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012;16:43-51.
27. Durston S, van Belle J, de Zeeuw P. Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;69:1178-1184.
28. Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 2010;67:701-711.
29. Yang H, Spence JS, Devous MD, Sr., et al. Striatal-limbic activation is associated with intensity of anticipatory anxiety. Psychiatry Res 2012;204:123-131.
30. Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA. Anxiety in Parkinson's disease: a critical review of experimental and clinical studies. Neuropharmacology 2012;62:115-124.
31. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010;35:192-216.
32. Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009;10:573-584.
33. Brooks SJ, O'Daly OG, Uher R, Treasure J, Campbell IC. Differential neural responses to food images in women with bulimia versus anorexia nervosa. PLoS One 2011;6:e22259.
34. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35:217-238.
35. Fineberg NA, Potenza MN, Chamberlain SR, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010;35:591-604.
36. Everitt BJ, Robbins TW. From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev 2013;37:1946-1954.
37. Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-1192.
38. Cavanna AE, Servo S, Monaco F, Robertson MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci 2009;21:13-23.
39. Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010;6:487-498.
40. Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 2002;72:12-21.
41. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
42. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.
43. Krack P, Hariz MI, Baunez C, Guridi J, Obeso JA. Deep brain stimulation: from neurology to psychiatry? Trends Neurosci 2010;33:474-484.
44. Starkstein SE, Brockman S, Hayhow BD. Psychiatric syndromes in Parkinson's disease. Curr Opin Psychiatry 2012;25:468-472.
45. O'Sullivan SS, Wu K, Politis M, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011;134:969-978.
46. Voon V, Mehta AR, Hallett M. Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol 2011;24:324-330.
47. Ray NJ, Strafella AP. Imaging impulse control disorders in Parkinson's disease and their relationship to addiction. J Neural Transm 2013;120:659-664.
48. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
49. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
50. Wichmann T, DeLong MR, Guridi J, Obeso JA. Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord 2011;26:1032-1041.
51. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
52. Benazzouz A, Boraud T, Féger J, Burbaud P, Bioulac B, Gross C. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Mov Disord 1996;11:627-632.
53. Tremblay L, Filion M, Bédard PJ. Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism. Brain Res 1989;498:17-33.
54. Pessiglione M, Guehl D, Rolland AS, Francois C, Hirsch EC, Feger J, Tremblay L. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J Neurosci 2005;25:1523-1531.
55. Pessiglione M, Tremblay L. Effect of dopamine depletion on reward-seeking behavior: evidence from human and non-human primates. In: Dreher JC, Tremblay L, editors. Reward and Decision-Making. Amsterdam: Academic, Elsevier; 2009:51-77.
56. Pessiglione M, Guehl D, Hirsch EC, Féger J, Tremblay L. Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism. I. Effects of task complexity. Eur J Neurosci 2004;19:426-436.
57. Pessiglione M, Czernecki V, Pillon B, Dubois B, Schüpbach M, Agid Y, Tremblay L. An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution. J Cogn Neurosci 2005;17:1886-1896.
58. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006;16:916-928.
59. Filion M, Tremblay L, Bédard PJ. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 1988;444:165-176.
60. Escola L, Michelet T, Douillard G, Guehl D, Bioulac B, Burbaud P. Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Ann Neurol 2002;52:581-587.
61. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-520.
62. Raz A, Vaadia E, Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000;20:8559-8571.
63. Guehl D, Pessiglione M, François C, Yelnik J, Hirsch EC, Féger J, Tremblay L. Tremor-related activity of neurons in the ‘motor’ thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism. Eur J Neurosci 2003;17:2388-2400.
64. Bezard E, Gross CE. Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Prog Neurobiol 1998;55:93-116.
65. Voon V, Fernagut PO, Wickens J, et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 2009;8:1140-1149.
66. Elsworth JD, Taylor JR, Sladek JR, Jr., Collier TJ, Redmond DE, Jr., Roth RH. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 2000;95:399-408.
67. Jan C, Pessiglione M, Tremblay L, Tandé D, Hirsch EC, François C. Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys. Eur J Neurosci 2003;18:2082-2086.
68. Mounayar S, Boulet S, Tandé D, et al. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain 2007;130:2898-2914.
69. Farley IJ, Price KS, Hornykiewicz O. Dopamine in the limbic regions of the human brain: normal and abnormal. Adv Biochem Psychopharmacol 1977;16:57-64.
70. Brooks DJ, Piccini P. Imaging in Parkinson's disease: the role of monoamines in behavior. Biol Psychiatry 2006;59:908-918.
71. Pessiglione M, Guehl D, Agid Y, Hirsch EC, Féger J, Tremblay L. Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease. Brain 2003;126:1392-1408.
72. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
73. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, Middelkoop HAM, Van Hilten JJ. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1182-1187.
74. Neumane S, Mounayar S, Jan C, et al. Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys. Neurobiol Dis 2012;48:27-39.
75. Beaudoin-Gobert M, Metereau E, Epinat J, et al. (2014) Acute MDMA intoxication abolishes L-DOPA-induced dyskinesia and behavioral hyperactivity in MPTP monkey model of Parkinson's disease. Washington DC: Society for Neuroscience; 2014.
76. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.
77. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010;133:1111-1127.
78. Grabli D, McCairn K, Hirsch EC, Agid Y, Féger J, François C, Tremblay L. Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain 2004;127:2039-2054.
79. Worbe Y, Baup N, Grabli D, et al. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cereb Cortex 2009;19:1844-1856.
80. Filion M, Tremblay L, Bédard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:152-161.
81. Matsumura M, Tremblay L, Richard H, Filion M. Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 1995;65:59-70.
82. McCairn KW, Bronfeld M, Belelovsky K, Bar-Gad I. The neurophysiological correlates of motor tics following focal striatal disinhibition. Brain 2009;132:2125-2138.
83. Pessiglione M, Guehl D, Jan C, François C, Hirsch EC, Féger J, Tremblay L. Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference. Eur J Neurosci 2004;19:437-446.
84. Mah L, Zarate CA, Jr., Singh J, Duan YF, Luckenbaugh DA, Manji HK, Drevets WC. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry 2007;61:765-775.
85. Ongür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000;10:206-219.
86. Barbas H, Saha S, Rempel-Clower N, Ghashghaei T. Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci 2003;4:25.
87. Ponseti J, Bosinski HA, Wolff S, et al. A functional endophenotype for sexual orientation in humans. Neuroimage 2006;33:825-833.
88. Bray S, O'Doherty J. Neural coding of reward-prediction error signals during classical conditioning with attractive faces. J Neurophysiol 2007;97:3036-3045.
89. Politis M, Loane C, Wu K, et al. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain 2013;136:400-411.
90. Sgambato-Faure V, Worbe Y, Epinat J, Féger J, Tremblay L. Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates. Brain Struct Funct 2014 Oct 11. doi: 10.1007/s00429-014-0911-9. [Epub ahead of print].
91. Lutz C, Well A, Novak M, Stereotypic and self-injurious behavior in rhesus macaques: a survey and retrospective analysis of environment and early experience. Am J Primatol 2003;60:1-15.
92. Kalin NH, Shelton SE, Fox AS, Oakes TR, Davidson RJ. Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry 2005;58:796-804.
93. Schoenbaum G, Setlow B. Lesions of nucleus accumbens disrupt learning about aversive outcomes. J Neurosci 2003;23:9833-9841.
94. Yanagimoto K, Maeda H. The nucleus accumbens unit activities related to the emotional significance of complex environmental stimuli in freely moving cats. Neurosci Res 2003;46:183-189.
95. Becerra L, Breiter HC, Wise R, Gonzalez RG, Borsook D. Reward circuitry activation by noxious thermal stimuli. Neuron 2001;32:927-946.
96. Jensen J, McIntosh AR, Crawley AP, Mikulis DJ, Remington G, Kapur S. Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 2003;40:1251-1257.
97. Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science 2007;315:515-518.
98. Delgado MR, Jou RL, Ledoux JE, Phelps EA. Avoiding negative outcomes: tracking the mechanisms of avoidance learning in humans during fear conditioning. Front Behav Neurosci 2009;3:33.
99. Cath DC, Spinhoven P, Hoogduin CA, et al. Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences? Psychiatry Res 2001;101:171-185.
100. Worbe Y, Mallet L, Golmard JL, et al. Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? PLoS One 2010;5:e12959.
101. Worbe Y, Epinat J, Féger J, Tremblay L. Discontinuous long-train stimulation in the anterior striatum in monkeys induces abnormal behavioral states. Cereb Cortex 2011;21:2733-2741.
102. Worbe Y, Sgambato-Faure V, Epinat J, et al. Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction. Cortex 2013;49:1126-1140.
103. Worbe Y, Gerardin E, Hartmann A, et al. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain 2010;133:3649-3660.
104. Mink JW. Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns? Adv Neurol 2001;85:113-122.
105. Kalanithi PS, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005;102:13307-13312.
106. Kataoka Y, Kalanithi PS, Grantz H, Schwartz ML, Saper C, Leckman JF, Vaccarino FM. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010;518:277-291.
107. Peterson BS, Thomas P, Kane MJ, et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003;60:415-424.
108. Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005;65:1253-1258.
109. Plenz D. When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function. Trends Neurosci 2003;26:436-443.
110. Berke JD. Functional properties of striatal fast-spiking interneurons. Front Syst Neurosci 2011;5:45.
111. Szydlowski SN, Pollak Dorocic IP, Planert H, Carlen M, Meletis K, Silberberg G. Target selectivity of feedforward inhibition by striatal fast-spiking interneurons. J Neurosci 2013;33:1678-1683.
112. Plenz D, Kitai ST. Up and down states in striatal medium spiny neurons simultaneously recorded with spontaneous activity in fast-spiking interneurons studied in cortex-striatum-substantia nigra organotypic cultures. J Neurosci 1998;18:266-283.
113. Koos T, Tepper JM. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 1999;2:467-492.
114. McCairn KW, Isoda M. Pharmacological animal models of tic disorders. Int Rev Neurobiol 2013;112:179-209.
115. Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends Neurosci 2006;29:175-182.
116. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996;50:381-425.
117. Gittis AH, Nelson AB, Thwin MT, Palop JJ, Kreitzer AC. Distinct roles of GABAergic interneurons in the regulation of striatal output pathways. J Neurosci 2010;30:2223-2234.
118. Mallet N, Le Moine C, Charpier S, Gonon F. Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J Neurosci 2005;25:3857-3869.
119. Spooren WP, Lynd-Balta E, Mitchell S, Haber SN. Ventral pallidostriatal pathway in the monkey: evidence for modulation of basal ganglia circuits. J Comp Neurol 1996;370:295-312.
120. Bevan MD, Booth PA, Eaton SA, Bolam JP. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci 1998;18:9438-9452.
121. Mallet N, Micklem BR, Henny P, et al. Dichotomous organization of the external globus pallidus. Neuron 2012;74:1075-1086.
122. Shink E, Bevan MD, Bolam JP, Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 1996;73:335-357.
123. Haber SN, Lynd-Balta E, Mitchell SJ. The organization of the descending ventral pallidal projections in the monkey. J Comp Neurol 1993;329:111-128.
124. Karachi C, Yelnik J, Tandé D, Tremblay L, Hirsch EC, Francois C. The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in primates. Mov Disord 2005;20:172-180.
125. Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical représentations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 1996;16:2671-2683.
126. Nambu A. A new dynamic model of the cortico-basal ganglia loop. Prog Brain Res 2004;143:461-466.
127. Haynes WIA, Haber SN. The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for basal ganglia models and deep brain stimulation. J Neurosci 2013;33:4804-4813.
128. Castrioto A, Lhommée E, Moro E, Krack P. Mood and behavioural effects of subthalamic stimulation in Parkinson's disease. Lancet Neurol 2014;13:287-305.
129. Kühn AA, Hariz MI, Silberstein P, et al. Activation of the subthalamic region during emotional processing in Parkinson disease. Neurology 2005;65:707-713.
130. Huebl J, Schoenecker T, Siegert S, et al. Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease. Mov Disord 2011;26:477-483.
131. Buot A, Welter ML, Karachi C, Pochon JB, Bardinet E, Yelnik J, Mallet L. Processing of emotional information in the human subthalamic nucleus. J Neurol Neurosurg Psychiatry 2013;84:1331-1338.
132. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism. Science 2007;318:1309-1312.
133. Ballanger B, van Eimeren T, Moro E, et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol 2009;66:817-824.
134. Baunez C, Nieoullon A, Amalric M. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. J Neurosci 1995;15:6531-6541.
135. Baunez C, Robbins TW. Bilateral lesions of the subthalamic nucleus induce multiple deficits in attentional performance in rats. Eur J Neurosci 1997;9:2086-2099.
136. Baunez C, Robbins TW. Effects of transient inactivation of the subthalamic nucleus by local muscimol and APV infusions on performance on the five-choice serial réaction time task in rats. Psychopharmacology 1999;141:57-65.
137. Baunez C, Dias C, Cador M, Amalric M. The subthalamic nucleus exerts opposite control on cocaine and ‘natural’ rewards. Nat Neurosci 2005;4:484-489.
138. Baunez C, Lardeux S. Frontal cortex-like functions of the subthalamic nucleus. Front Neurosci 2011;;5:83.
139. Lhommée E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain 2012;135:1463-1477.
140. Rouaud T, Lardeux S, Panayotis N, Paleressompoulle D, Cador M, Baunez C. Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation. Proc Natl Acad Sci U S A 2010;107:1196-1200.
141. Baup N, Grabli D, Karachi C, et al. High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 2008;28:8785-8788.
142. Mallet L, Polosan M, Jaafari N, et al.; STOC Study Group. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008;359:2121-2134.
143. Blomstedt P, Sjöberg RL, Hansson M, Bodlund O, Hariz MI. Deep brain stimulation in the treatment of obsessive-compulsive disorder. World Neurosurg 2013;80:e245-e253.
144. Di Matteo V, Pierucci M, Esposito E, Crescimanno G, Benigno A, Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog Brain Res 2008;172:423-463.
145. Huot P, Fox SH. The serotonergic system in motor and non-motor manifestations of Parkinson's disease. Exp Brain Res 2013;230:463-476.
146. Beaudoin-Gobert M, Sgambato-Faure V. Serotonergic pharmacology in animal models: from behavioral disorders to dyskinesia. Neuropharmacology 2014;81:15-30.
147. Steeves TD, Fox SH. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 2008;172:495-513.
148. Buse J, Schoenefeld K, Münchau A, Roessner V. Neuromodulation in Tourette syndrome: dopamine and beyond. Neurosci Biobehav Rev 2013;37:1069-1084.
149. Bronfeld M, Israelashvili M, Bar-Gad I. Pharmacological animal models of Tourette syndrome. Neurosci Biobehav Rev 2013;37:1101-1119.
150. Roessner V, Schoenefeld K, Buse J, Bender S, Ehrlich S, Münchau A. Pharmacological treatment of tic disorders and Tourette Syndrome. Neuropharmacology 2013;68:143-149.
151. Wood MD, Wren PB. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Prog Brain Res 2008;172:213-230.
152. Oades RD. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog Brain Res 2008;172:543-565.
153. Do J, Kim JI, Bakes J, Lee K, Kaang BK. Functional roles of neurotransmitters and neuromodulators in the dorsal striatum. Learn Mem 2012;20:2128.
154. Carli M, Invernizzi RW. Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task. Front Neural Circuits 2014;8:58.
155. Van Velzen LS, Vriend C, de Wit SJ, van den Heuvel OA. Response inhibition and interference control in obsessive-compulsive spectrum disorders. Front Hum Neurosci 2014;8:419.
156. Graff-Guerrero A, Willeit M, Ginovart N, et al. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans. Hum Brain Mapp 2008;29:400-410.
157. Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 2014;174:1930-1933.
158. Varnäs K, Nyberg S, Halldin C, et al. Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain. J Cereb Blood Flow Metab 2011;31:113-123.
159. Murrough JW, Henry S, Hu J, Gallezot JD, Planeta-Wilson B, Neumaier JF, Neumeister A. Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology 2011;213:547-553.
160. Heller AS, Johnstone T, Light SN, Peterson MJ, Kolden GG, Kalin NH, Davidson RJ. Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. Am J Psychiatry 2013;170:197-206.
161. Marsden CD. The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology 1982;32:514-539.